sac faces insider trading probe on medimmune: report
sac capital advisors lp faces an insider trading probe from the u.s. securities and exchange commission related to the $15 billion takeover of biotechnology firm medimmune inc, the wall street journal reported, citing people familiar with the matter.
http://feeds.reuters.com/~r/reuters/businessnews/~3/s4sw9glidlo/us-saccapital-idustre75014s20110601
10361
01 Jun 2011 13:56:28
reuters
business